Recurrent Disease Active Not Recruiting Phase 2 Trials for Fludarabine (DB01073)

DBCOND0028541 (Recurrent Disease)Active Not Recruiting2 IdentifierTitlePurposeDrugs
NCT00036738Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or NilotinibTreatment
NCT00003145Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid LeukemiaTreatment